Aspo Plc - Managers' Transactions - Taru Uotila
Globenewswire· 2026-03-03 12:00
Erkka Repo CFO Distribution: Nasdaq Helsinki www.aspo.com Aspo Plc - Managers' Transactions - Taru Uotila Person subject to the notification requirement Name: Taru Uotila Position: Other senior manager Issuer: Aspo Oyj LEI: 7437000TB0GHDHLPX677 Notification type: INITIAL NOTIFICATION Reference number: 145277/6/4 Transaction date: 2026-03-02 Outside a trading venue Instrument type: SHARE ISIN: FI0009008072 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1): Volume: 1808 Unit pr ...
Plug Power Welcomes Jose Luis Crespo as Chief Executive Officer
Globenewswire· 2026-03-03 12:00
The leadership transition reinforces continuity in Plug's strategy that concentrates on electrolyzers, fuel cells, and hydrogen generation assets that make hydrogen energy accessible for commercial and industrial applications globally. The strategy also includes our previously communicated financial objectives, including targeting: positive EBITDAS by the end of 2026, positive operating income by the end of 2027, and full profitability by the end of 2028, while still growing the Company substantially and in ...
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
Globenewswire· 2026-03-03 12:00
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) ("AtaiBeckley" or "Company"), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced a successful End‑of‑Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of BPL‑003, the Company's proprietary intranasal formulation of mebufotenin benzoate, for treatment‑resistant de ...
Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference
Globenewswire· 2026-03-03 12:00
About Tenax Therapeutics Tenax Therapeutics, Inc. is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies. The Company owns global rights to develop and commercialize levosimendan, which it is developing for the treatment of PH-HFpEF, the most prevalent form of pulmonary hypertension globally, for which no product has been approved to date. For more information, visit www.tenaxthera.com. Tenax Therapeutics' common stock is listed on The Nasda ...
Strata Critical Medical Announces Fourth Quarter 2025 Results
Globenewswire· 2026-03-03 12:00
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the fourth quarter ended December 31, 2025. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only. The results of the divested Passenger business have been reclassified as discontinued operations in all periods. Beginning with the fourth quarter of 2025, following the acquisition and integr ...
OTC Markets Group Welcomes Golconda Gold Ltd. to OTCQX
Globenewswire· 2026-03-03 12:00
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Golconda Gold Ltd. (TSX-V: GG; OTCQX: GGGOF), an unhedged gold producer, has qualified to trade on the OTCQX® Best Market. Golconda Gold Ltd. upgraded to OTCQX from the OTCQB® Venture Market. OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven dis ...
Pilot had weaker performance in ‘25: Berkshire letter
Yahoo Finance· 2026-03-03 12:00
Pilot became a fully-owned subsidiary of Berkshire Hathaway early in 2024 after it acquired the last 20% of the business it had not already bought from the Haslam family that founded and controlled the nation's largest network of travel centers. Data and commentary on Pilot's financial condition has been relatively bare bones in Berkshire Hathaway's quarterly earnings reports since then. But there's a fuller discussion in the 2025 annual report released Saturday. Much of the increased discussion about the b ...
Advantage Solutions Reports Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-03-03 12:00
Strong cash flow performance resulted in ending the quarter with $241million of cash, up $40 million sequentially Completion of non-core divestitures, planned debt refinancing and upcoming reverse stock split Expectflat to up low-single digit revenue growth in 2026, Adjusted EBITDA flat to down mid-single digits ST. LOUIS, March 03, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) ("Advantage," "Advantage Solutions," the "Company," "we," or "our"), a leading business solutions provider to con ...
Bank of America Announces Redemption of JPY 27,800,000,000 0.534% Fixed/Floating Rate Senior Notes, due March 18, 2027
Prnewswire· 2026-03-03 12:00
Bank of America Announces Redemption of JPY 27,800,000,000 0.534% Fixed/Floating Rate Senior Notes, due March 18, 2027 [Accessibility Statement] Skip NavigationCHARLOTTE, N.C., March 3, 2026 /PRNewswire/ -- Bank of America Corporation announced today that it will redeem on March 18, 2026 all JPY 27,800,000,000 principal amount outstanding of its 0.534% Fixed/Floating Rate Senior Notes, due March 18, 2027 (ISIN: XS1963076051; Common Code: 196307605; Series Number: 859) (the "Notes").The Notes were issued und ...
EVgo Inc. Reports Record Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-03-03 12:00
Total Q4 Revenues Increased 75% with Record Charging Network Revenue of $64 Million Initiates 2026 guidance of $410 - $470 Million of Revenue and $(20) - $20 Million of Adjusted EBITDA LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) -- EVgo Inc. (Nasdaq: EVGO) ("EVgo" or the "Company") one of the nation's largest providers of public fast charging infrastructure for electric vehicles (EVs) announced results for the fourth quarter ended December 31, 2025. Management will host a webcast today at 8 a.m. ET / 5 a.m ...